TipRanks
Supernus Pharmaceuticals (GB:0LB2)
LSE:0LB2
UK Market

Supernus Pharmaceuticals (0LB2) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Supernus Pharmaceuticals’s (0LB2) Moving Averages Convergence Divergence (MACD) indicator is -1.50, suggesting Supernus Pharmaceuticals is a Buy.
Supernus Pharmaceuticals’s (0LB2) 20-Day exponential moving average is 43.52, while Supernus Pharmaceuticals’s (0LB2) share price is $44.72, making it a Sell.
Supernus Pharmaceuticals’s (0LB2) 50-Day exponential moving average is 45.26, while Supernus Pharmaceuticals’s (0LB2) share price is $44.72, making it a Sell.

Supernus Pharmaceuticals (0LB2) Pivot Points

Sep 17, 2026, 08:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
40.89
40.89
40.89
40.89
40.89
40.89
40.89
Fibonacci
40.89
40.89
40.89
40.89
40.89
40.89
40.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Supernus Pharmaceuticals (0LB2) Moving Averages

Sep 17, 2026, 08:59 PM
Period
Simple
Exponential
MA5
41.40Sell
41.48Sell
MA10
42.42Sell
42.25Sell
MA20
43.95Sell
43.52Sell
MA50
46.15Sell
45.26Sell
MA100
46.73Sell
46.49Sell
MA200
48.44Sell
47.78Sell
Supernus Pharmaceuticals’s (0LB2) 10-Day exponential moving average is 42.25, while Supernus Pharmaceuticals’s (0LB2) share price is $44.72, making it a Sell.
Supernus Pharmaceuticals’s (0LB2) 100-Day exponential moving average is 46.49, while Supernus Pharmaceuticals’s (0LB2) share price is $44.72, making it a Sell.
Supernus Pharmaceuticals’s (0LB2) stock price is $44.72 and Supernus Pharmaceuticals’s (0LB2) 50-day simple moving average is 46.15, creating a Sell signal.
Supernus Pharmaceuticals’s (0LB2) stock price is $44.72 and Supernus Pharmaceuticals’s (0LB2) 100-day simple moving average is 46.73, creating a Sell signal.
Supernus Pharmaceuticals’s (0LB2) stock price is $44.72 and Supernus Pharmaceuticals’s (0LB2) 200-day simple moving average is 48.44, creating a Sell signal.

Supernus Pharmaceuticals (0LB2) Technical Indicators

Sep 17, 2026, 08:59 PM
Name
Value
Implied Action
RSI (14)
32.11
Neutral
STOCH (9,6)
10.47
Buy
STOCHRSI (14)
6.97
Buy
MACD (12,26)
-1.50
Buy
ADX (14)
22.13
Neutral
Williams %R
-100.00
Buy
CCI (14)
-124.63
Buy
ATR (14)
1.14
-
Ultimate Oscillator
17.05
Sell
ROC
-8.63
Sell
Supernus Pharmaceuticals’s (0LB2) Relative Strength Index (RSI) is 32.11, creating a Neutral signal.
Supernus Pharmaceuticals’s (0LB2) Trend Strength Indicator (ADX) is 22.13, creating a Neutral signal.
Supernus Pharmaceuticals’s (0LB2) Commodity Channel Index (CCI) is -124.63, creating a Buy signal.
Supernus Pharmaceuticals’s (0LB2) Price Rate of Change (ROC) is -8.63, creating a Sell signal.

FAQ

Is 0LB2 a Buy, Hold, or Sell?
Based on 0LB2’s technical indicators, 0LB2 is a Sell.
    What is 0LB2’s RSI (14)?
    0LB2’s RSI (14) is 32.11, which suggests 0LB2 is a Neutral.
      What is 0LB2’s MACD?
      0LB2’s MACD is -1.50, which suggests 0LB2 is a Buy.
        What is 0LB2’s 5-day moving average?
        0LB2’s 5-day moving average is 41.40, which suggests 0LB2 is a Sell.
          What is 0LB2’s 20-day moving average?
          0LB2 20-day moving average is 43.95, which suggests 0LB2 is a Sell.
            What is 0LB2’s 50-day moving average?
            0LB2’s 50-day moving average is 46.15, which suggests 0LB2 is a Sell.
              What is 0LB2’s 200-day moving average?
              0LB2’s 200-day moving average is 48.44, which suggests 0LB2 is a Sell.
                What is 0LB2’s Williams % R (14)?
                0LB2’s Williams % R (14) is -100.00, which suggests 0LB2 is a Buy.
                  What is 0LB2’s CCI (14)?
                  0LB2’s CCI (14) is -124.63, which suggests 0LB2 is a Buy.
                    What is the share price of Supernus Pharmaceuticals?